THERAMAB LLC has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are UBIPROTEIN CORP, BIOVERATIV USA INC and SALPEP BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hanke Thomas | 9 |
#2 | Guntermann Christine | 4 |
#3 | Trischler Martin | 4 |
#4 | Huenig Thomas | 3 |
#5 | Matskevich Alexey | 3 |
#6 | Chuvpilo Sergey | 3 |
#7 | Tyrsin Dmitry | 3 |
#8 | Hunig Thomas | 1 |
#9 | Luehder Fred | 1 |
#10 | Lin Chia-Huey | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015198147A1 | Compositions and methods for safe and effective immunotherapy | |
US2015150968A1 | Use of cd28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections | |
US2010168400A1 | Superagonistic anti-CD28 antibodies | |
EP2497829A1 | Super-agonistic anti-CD-28 antibodies |